Articles From: MWV to Release Second Quarter 2014 Results and Host Conference Call to MYOS Corporation Reports 2014 Second Quarter Results


MeadWestvaco Corporation (NYSE: MWV ), a global leader in packaging and packaging solutions will release its second quarter results on Wednesday, July 30, 2014, before the market opens.
Sign-up for MWV to Release Second Quarter 2014 Results and Host Conference Call investment picks
2014/8/25
ZHONGSHAN, China , Aug.
Sign-up for MY Reports Second Quarter Unaudited Results, Signed Order Backlog Reaches 3.6GW investment picks
2014/8/8
Earnings Conference Call and Webcast to be Held on August 25, 2014 at 8:00 am (Eastern)/5:00 am (Pacific)/August 25, 2014 8:00 pm (China) ZHONGSHAN, China , Aug.
Sign-up for MY to Announce Second Quarter 2014 Financial Results on Monday, August 25, 2014 investment picks
2014/7/15
http://media.marketwire.com/attachments/201404/243051_mycomlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1131027&ProfileId=051205&sourceType=1 MOUNTAIN VIEW, CA --
Sign-up for My.com Study on Email Usage Shows 90% of Internet Users "Compulsively" Check Email investment picks
Acxiom® (NASDAQ: ACXM), an enterprise data, analytics and software-as-a-service company, today announced MyAcxiomPartner.com , an easy-to-use self-service site that enables business owners and marketers the ability to build and launch targeted, multichannel advertising campaigns at a fraction of the cost of previously available solutions.
Sign-up for MyAcxiomPartner.com Sets the Standard for Simpler, More Effective Social and Mobile Ad Campaigns investment picks
2014/7/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1130403&ProfileId=051205&sourceType=1 FOLSOM, CA --
Sign-up for MyECheck Leases New Offices, Hires Employees, Engages Patent Litigators investment picks
WINDSOR, Conn., June 16, 2014 (GLOBE NEWSWIRE) -- SS&C Technologies Holdings, Inc. (Nasdaq:SSNC) , a global provider of financial services software and software-enabled services, today announced that Myer Family Company (MFCo) has renewed its contract for use of SS&C's Global Wealth Platform (GWP). "We provide our clients with the knowledge, insight and independence that enables them to shape the future of their wealth and deal with the complexities and responsibilities that come from managing wealth," said Mathew Browning, Chief Operating Officer, MFCo.
Sign-up for Myer Family Company Renews Relationship With SS&C investment picks
Myers Industries, Inc. (NYSE: MYE) announced today that Todd Smith will step out of his role as Vice President, General Manager of the Distribution Segment to assume the role of Vice President, General Manager of Akro-Mils, a core Material Handling business for the Company.
Sign-up for Myers Industries Announces Leadership Changes in its Distribution and Material Handling Segments investment picks
Myers Industries, Inc. (NYSE: MYE) today announced that it intends to report financial results for the second quarter ended June 30, 2014, on Thursday, July 24, 2014, before the market opens.
Sign-up for Myers Industries Announces Reporting Date for 2014 Second Quarter Results; Conference Call Scheduled investment picks
Myers Industries, Inc. (NYSE: MYE) announced today that it has completed the sale of WEK Industries, Inc. to Industrial Opportunity Partners, owners of Toledo Molding and Die, Inc. for approximately $19.5 million.
Sign-up for Myers Industries Completes Sale of WEK Industries, Inc. and Announces Segment Reporting Realignment investment picks
The Board of Directors of Myers Industries, Inc. (NYSE: MYE) declared on Thursday, July 31, 2014 a regular quarterly dividend of $0.13 per share payable October 6, 2014, to shareholders of record as of September 5, 2014.
Sign-up for Myers Industries Declares Quarterly Dividend investment picks
Myers Industries, Inc. (NYSE: MYE) today announced results for the second quarter ended June 30, 2014.
Sign-up for Myers Industries Reports 2014 Second Quarter Results investment picks
PITTSBURGH , Aug.
Sign-up for Mylan Launches First Generic Klor-Con® Extended-Release Tablets investment picks
PITTSBURGH , Sept.
Sign-up for Mylan Launches Generic Boniva® Injection investment picks
PITTSBURGH , July 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Telmisartan Tablets USP, 20 mg, 40 mg and 80 mg, the generic version of Boehringer Ingelheim's Micardis® Tablets.
Sign-up for Mylan Launches Generic Micardis® Tablets investment picks
PITTSBURGH , Aug.
Sign-up for Mylan Launches Generic Precedex™ Injection - Another Key Product Approval investment picks
PITTSBURGH , Aug.
Sign-up for Mylan Launches Generic Xeloda® Tablets investment picks
Narrows 2014 Adjusted Diluted EPS Guidance Range to $3.25 to $3.45 Reaffirms Opportunity to Accelerate 2018 Target of at Least $6.00 in Adjusted Diluted EPS PITTSBURGH , Aug.
Sign-up for Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance investment picks
Mylan to Host Investor Day on Sept.
Sign-up for Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014 investment picks
Brings Differentiated, Attractive Product Portfolio and Enhanced Commercial Platform, Diversifying Mylan's Business and Adding New Sales Channels in Acquired Markets Immediately and Significantly Accretive to Earnings, with Opportunity to Accelerate Target of at Least $6.00 in Adjusted Diluted EPS in 20181 Creates Significantly Enhanced Financial Flexibility and More Competitive Global Tax Structure for Future Opportunities PITTSBURGH , July 14, 2014 /PRNewswire/ -- Mylan Inc. (NASDAQ: MYL) today announced that it has entered into a definitive agreement with Abbott (NYSE: ABT) whereby Mylan will acquire Abbott's non-U.S. developed markets specialty and branded generics business ("the Assets") in an all-stock transaction.
Sign-up for Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction investment picks
Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH , Sept.
Sign-up for Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen investment picks
District Court Judge Orders Apotex to Immediately Recall the Authorized Generic from its Direct Customers and to Stop Selling and Supplying the Product PITTSBURGH , July 23, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a temporary restraining order against Apotex Inc. and Apotex Corporation in litigation relating to Paroxetine CR, the authorized generic of GlaxoSmithKline's Paxil ® CR.
Sign-up for Mylan Wins Motion for Temporary Restraining Order Against Apotex for Authorized Generic of Paxil® CR investment picks
PITTSBURGH , July 17, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that the U.S. District Court for the District of New Jersey granted its motion for a permanent injunction against GlaxoSmithKline (GSK) in relation to Paroxetine CR, the generic version of GSK's Paxil ® CR.
Sign-up for Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0957533001&sourceType=1 http://media3.marketwire.com/logos/20120411-mymetics_logo_200.jpg EPALINGES, SWITZERLAND --
Sign-up for Mymetics Signs Agreement to Manufacture Virosome based HER-Vaxx Cancer Immunotherapy investment picks
http://media.marketwire.com/attachments/201406/76739_myos.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1131831&ProfileId=051205&sourceType=1 CEDAR KNOLLS, NJ --
Sign-up for MYOS Corporation Announces Agreement With Cloud Pharmaceuticals, Inc. to Develop Small Molecules Targeting Sarcopenia and Cachexia investment picks
http://media.marketwire.com/attachments/201406/76739_myos.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1130705&ProfileId=051205&sourceType=1 CEDAR KNOLLS, NJ --
Sign-up for MYOS Corporation Appoints World Renowned Scientific Visionary and Entrepreneur, J. Craig Venter, Ph.D., to Board of Directors investment picks
- Patent will protect MYOS' intellectual property portfolio for Fortetropin through 2033 – CEDAR KNOLLS, N.J., July 24, 2014 (GLOBE NEWSWIRE) -- MYOS Corporation ("MYOS" or the "Company") (Nasdaq:MYOS) , an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, announced today that it recently received a Notice of Allowance from the U.S. Patent and Trademark Office ("USPTO") for U.S. Patent Application Serial No.
Sign-up for MYOS Corporation Receives Notice of Allowance of U.S. Patent Application for Proprietary Manufacturing Methods of Fortetropin investment picks
http://media.marketwire.com/attachments/201408/78060_MYOS.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1137787&ProfileId=051205&sourceType=1 CEDAR KNOLLS, NJ --
Sign-up for MYOS Corporation Reports 2014 Second Quarter Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: MWV to Release Second Quarter 2014 Results and Host Conference Call to MYOS Corporation Reports 2014 Second Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices